169 related articles for article (PubMed ID: 34351421)
1. Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasia.
Wu J; Gupta R; Barreto J; Doo P; Joseph NM; Lee JC; Perry A; Chang SM; Berger MS; Solomon DA
Neuro Oncol; 2021 Oct; 23(10):1798-1800. PubMed ID: 34351421
[No Abstract] [Full Text] [Related]
2. Primary CNS Alveolar Rhabdomyosarcoma: Importance of Epigenetic and Transcriptomic Assays for Accurate Diagnosis.
Jour G; Serrano J; Koelsche C; Jones DTW; von Deimling A; Allen J; Snuderl M
J Neuropathol Exp Neurol; 2019 Nov; 78(11):1073-1075. PubMed ID: 31553442
[TBL] [Abstract][Full Text] [Related]
3. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
4. The potential for epigenetic analysis of paediatric CNS tumours to improve diagnosis, treatment and prognosis.
Sexton-Oates A; MacGregor D; Dodgshun A; Saffery R
Ann Oncol; 2015 Jul; 26(7):1314-24. PubMed ID: 25605740
[TBL] [Abstract][Full Text] [Related]
5. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic profiling for the molecular classification of metastatic brain tumors.
Orozco JIJ; Knijnenburg TA; Manughian-Peter AO; Salomon MP; Barkhoudarian G; Jalas JR; Wilmott JS; Hothi P; Wang X; Takasumi Y; Buckland ME; Thompson JF; Long GV; Cobbs CS; Shmulevich I; Kelly DF; Scolyer RA; Hoon DSB; Marzese DM
Nat Commun; 2018 Nov; 9(1):4627. PubMed ID: 30401823
[TBL] [Abstract][Full Text] [Related]
7. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of multiple genes in primary CNS lymphoma.
Chu LC; Eberhart CG; Grossman SA; Herman JG
Int J Cancer; 2006 Nov; 119(10):2487-91. PubMed ID: 16858686
[TBL] [Abstract][Full Text] [Related]
9. The value of epigenetic biomarkers in breast cancer.
Parrella P
Biomark Med; 2018 Sep; 12(9):937-940. PubMed ID: 30041537
[No Abstract] [Full Text] [Related]
10. Tumor purity and differential methylation in cancer epigenomics.
Wang F; Zhang N; Wang J; Wu H; Zheng X
Brief Funct Genomics; 2016 Nov; 15(6):408-419. PubMed ID: 27199459
[TBL] [Abstract][Full Text] [Related]
11. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Torchia J; Golbourn B; Feng S; Ho KC; Sin-Chan P; Vasiljevic A; Norman JD; Guilhamon P; Garzia L; Agamez NR; Lu M; Chan TS; Picard D; de Antonellis P; Khuong-Quang DA; Planello AC; Zeller C; Barsyte-Lovejoy D; Lafay-Cousin L; Letourneau L; Bourgey M; Yu M; Gendoo DMA; Dzamba M; Barszczyk M; Medina T; Riemenschneider AN; Morrissy AS; Ra YS; Ramaswamy V; Remke M; Dunham CP; Yip S; Ng HK; Lu JQ; Mehta V; Albrecht S; Pimentel J; Chan JA; Somers GR; Faria CC; Roque L; Fouladi M; Hoffman LM; Moore AS; Wang Y; Choi SA; Hansford JR; Catchpoole D; Birks DK; Foreman NK; Strother D; Klekner A; Bognár L; Garami M; Hauser P; Hortobágyi T; Wilson B; Hukin J; Carret AS; Van Meter TE; Hwang EI; Gajjar A; Chiou SH; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheinemann K; Fleming AJ; Johnston DL; Michaud J; Zelcer S; Hammond R; Afzal S; Ramsay DA; Sirachainan N; Hongeng S; Larbcharoensub N; Grundy RG; Lulla RR; Fangusaro JR; Druker H; Bartels U; Grant R; Malkin D; McGlade CJ; Nicolaides T; Tihan T; Phillips J; Majewski J; Montpetit A; Bourque G; Bader GD; Reddy AT; Gillespie GY; Warmuth-Metz M; Rutkowski S; Tabori U; Lupien M; Brudno M; Schüller U; Pietsch T; Judkins AR; Hawkins CE; Bouffet E; Kim SK; Dirks PB; Taylor MD; Erdreich-Epstein A; Arrowsmith CH; De Carvalho DD; Rutka JT; Jabado N; Huang A
Cancer Cell; 2016 Dec; 30(6):891-908. PubMed ID: 27960086
[TBL] [Abstract][Full Text] [Related]
12. [Epigenetic regulation and the role of non-coding RNAs in gliomas].
Deguchi S; Kondo Y; Natsume A
No Shinkei Geka; 2014 Aug; 42(8):701-9. PubMed ID: 25087757
[No Abstract] [Full Text] [Related]
13. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.
Capper D; Stichel D; Sahm F; Jones DTW; Schrimpf D; Sill M; Schmid S; Hovestadt V; Reuss DE; Koelsche C; Reinhardt A; Wefers AK; Huang K; Sievers P; Ebrahimi A; Schöler A; Teichmann D; Koch A; Hänggi D; Unterberg A; Platten M; Wick W; Witt O; Milde T; Korshunov A; Pfister SM; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):181-210. PubMed ID: 29967940
[TBL] [Abstract][Full Text] [Related]
14. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
15. Use of DNA methylation profiling in translational oncology.
Ortiz-Barahona V; Joshi RS; Esteller M
Semin Cancer Biol; 2022 Aug; 83():523-535. PubMed ID: 33352265
[TBL] [Abstract][Full Text] [Related]
16. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.
Azizgolshani N; Petersen CL; Chen Y; Levy JJ; Salas LA; Perreard L; Nguyen LN; Christensen BC
Clin Epigenetics; 2021 Sep; 13(1):176. PubMed ID: 34538273
[TBL] [Abstract][Full Text] [Related]
17. Next-generation technologies and data analytical approaches for epigenomics.
Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T
Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic DNA methylome profiling and the WHO 5
Frank S; Hench J
Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
[TBL] [Abstract][Full Text] [Related]
19. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K
Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175
[TBL] [Abstract][Full Text] [Related]
20. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
Pickles JC; Stone TJ; Jacques TS
J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
